Rounds / Metagen Therapeutics
MT
Metagen Therapeutics raises ¥190M (Series B extension (1st close))
Therapeutics based on gut microbiota.
- Company
- Metagen Therapeutics
- Reported
- 4 Sept 2026 · that week's brief
- Stage
- Series B extension (1st close) · 「シリーズB」 · B
- Amount
- ¥190M1 · as announced: 「総額1.9億円」
- Breakdown
- Equity ¥190M
- Status
- In scopeNot yet registry-confirmed
- Investors
- 15th Rock
- Sector
- BiotechDeep tech
- Source
- Primary release (PR TIMES) · BRIDGE coverage
1 ≈ ~$1.22M at the ECB reference rate on 2026-09-04 (¥1 = $0.0064). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →